This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Barnes, M. J. Articles by Newell, D. R. Search for Related Content PubMed PubMed Citation Articles by Barnes, M. J. Articles by Newell, D. R.

Impact of Polyglutamation on Sensitivity to Raltitrexed and Methotrexate in Relation to Drug-induced Inhibition of de Novo Thymidylate and Purine Biosynthesis in CCRF-CEM Cell Lines¹

Cancer Research Unit, University of Newcastle, Newcastle upon Tyne NE2 4HH, United Kingdom [M. J. B., G. A. T., J. A. C., J. L., D. R. N.]; Department of Child Health, Royal Victoria Infirmary, Newcastle upon Tyne NE1 4LP, United Kingdom [E. J. E., A. D. J. P.]; CRC Centre for Cancer Therapeutics, Institute of Cancer Research, Sutton, Surrey SM2 5NG, United Kingdom [G. W. A., A. H.]; and Roswell Park Cancer Institute, New York State Department of Health, Buffalo, New York 14263-0001 [J. J. M.]

The aim of this study was to investigate the influence of folylpolyglutamyl synthetase (FPGS) activity on the cellular pharmacology of the classical antifolates raltitrexed and methotrexate (MTX) using two human leukemia cell lines, CCRF-CEM and CCRF-CEM:RC2^Tomudex. Cell growth inhibition and drug-induced inhibition of de novo thymidylate and purine biosynthesis were used as measures of the cellular effects of the drugs.

CCRF-CEM:RC2^Tomudex cells had <11% of the FPGS activity of CCRF-CEM cells, whereas MTX uptake and TS activity were equivalent. In CCRF-CEM:RC2^Tomudex cells, MTX polyglutamate formation was undetectable after exposure to 1 µM [³H]MTX for 24 h. After exposure to 0.1 µM raltitrexed, levels of total intracellular raltitrexed-derived material in CCRF-CEM:RC2^Tomudex cells were 30- to 50-fold lower than in the CCRF-CEM cell line. CCRF-CEM:RC2^Tomudex cells were >1000-fold resistant to raltitrexed and 6-fold resistant to lometrexol but sensitive to MTX and nolatrexed when exposed to these antifolates for 96 h. After 6 h of exposure, CCRF-CEM cells retained sensitivity to MTX and raltitrexed but were less sensitive to lometrexol-mediated growth inhibition. In contrast, CCRF-CEM:RC2^Tomudex cells were markedly insensitive to raltitrexed, lometrexol, and to a lesser degree, MTX. Simultaneous measurement of de novo thymidylate and purine biosynthesis revealed 90% inhibition of TS activity by 100 nM MTX in both cell lines, whereas inhibition of de novo purine synthesis was only observed in CCRF-CEM cells, and only after exposure to 1000 nM MTX. Ten nM raltitrexed induced >90% inhibition of TS activity in CCRF-CEM cells, whereas in CCRF-CEM:RC2^Tomudex cells, there was no evidence of inhibition after exposure to 1000 nM raltitrexed.

These studies demonstrate that polyglutamation is a critical determinant of the cellular pharmacology of both raltitrexed and MTX, markedly influencing potency in the case of raltitrexed and locus of action in the case of MTX.

This article has been cited by other articles:

				E. Nduati, S. Hunt, E. M. Kamau, and A. Nzila 2,4-Diaminopteridine-Based Compounds as Precursors for De Novo Synthesis of Antifolates: a Novel Class of Antimalarials Antimicrob. Agents Chemother., September 1, 2005; 49(9): 3652 - 3657. [Abstract] [Full Text] [PDF]

				P Ranganathan, S Eisen, W M Yokoyama, and H L McLeod Will pharmacogenetics allow better prediction of methotrexate toxicity and efficacy in patients with rheumatoid arthritis? Ann Rheum Dis, January 1, 2003; 62(1): 4 - 9. [Abstract] [Full Text] [PDF]